The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Merus Labs International Inc

TSX: MSL
Delayed quote

$1.11

Today's change-0.05 -4.31%
Updated January 17 2:10 PM EST. Delayed by at least 15 minutes.
 

Merus Labs International Inc

TSX: MSL
Delayed quote

$1.11

Today's change-0.05 -4.31%
Updated January 17 2:10 PM EST. Delayed by at least 15 minutes.

Merus Labs International Inc crosses below 20-day moving average

Merus Labs International Inc is sharply lower today, dropping $0.05 or 4.31% to $1.11 and crossing below its 20-day moving average. Over the last five days, shares have lost 1.77% and 34.71% over the last 52 weeks. This security has underperformed the S&P TSX by 62.86% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.09
Updated January 17 2:10 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-10.39%

Merus Labs International Inc has a net profit margin of -10.39%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.04%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty

Latest Company News

View more News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue30262016
Total other revenue--------
Total revenue30262016
Gross profit19171411
Total cost of revenue11964
Total operating expense27282116
Selling / general / administrative8534
Research & development--------
Depreciation / amortization101097
Interest expense (income), net operating--------
Unusual expense (income)0020
Other operating expenses, total--------
Operating income3-2-10
Interest income (expense), net non-operating-3-2-3-1
Gain (loss) on sale of assets--------
Other--------
Income before tax0-5-3-1
Income after tax0-5-3-1
Income tax, total0000
Net income0-5-3-1
Total adjustments to net income--------
Net income before extra. items0-5-3-1
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items0-5-3-1
Inc. avail. to common incl. extra. items0-5-3-1
Diluted net income0-5-3-1
Dilution adjustment----0--
Diluted weighted average shares117117107102
Diluted EPS excluding extraordinary itemsvalue per share0.00-0.04-0.03-0.01
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.00-0.04-0.02-0.01